Research ArticleOriginal Article
Open Access

Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease

Associations with laboratory findings, comorbidities, and medications

Ismail Erturk, Fatih Yesildal, Ramazan Acar, Taner Ozgurtas and Kenan Saglam
Saudi Medical Journal June 2018, 39 (6) 586-591; DOI: https://doi.org/10.15537/smj.2018.6.22024

Article Information

vol. 39 no. 6 586-591
DOI 
https://doi.org/10.15537/smj.2018.6.22024
PubMed 
29915853
Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Received June 16, 2018
  • Accepted April 25, 2018
  • Published online June 1, 2018.
Copyright & Usage 
Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

  1. Ismail Erturk, MD, PhD⇑,
  2. Fatih Yesildal, MD, PhD,
  3. Ramazan Acar, MD, PhD,
  4. Taner Ozgurtas, MD and
  5. Kenan Saglam, MD
  1. From the Department of Internal Medicine (Erturk, Acar, Saglam), Department of Biochemistry (Ozgurtas), University of Health Sciences, Gulhane Education and Research Hospital, Ankara, and Department of Medical Biochemistry (Yesildal), Istanbul Medeniyet University, Goztepe Education and Research Hospital, Istanbul, Turkey
  1. Address correspondence and reprint request to: Dr. Ismail Erturk, Department of Internal Medicine, University of Health Sciences, Gulhane School of Medicine, Etlik, Ankara, Turkey. E-mail: ierturk{at}hotmail.com ORCID ID: https://orcid.org/0000-0001-6835-0988
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section